Related Experiment Videos
Double-stranded RNA-dependent protein kinase (PKR) is downregulated by phorbol ester
Yan Zhou1, Barbara I Chase, Mark Whitmore
1Department of Chemistry, Cleveland State University, OH 44115, USA.
The FEBS Journal
|March 30, 2005
Summary
Phorbol 12-myristate 13-acetate (PMA) reduces double-stranded RNA-dependent protein kinase (PKR) activity by triggering its degradation. Protein kinase C (PKC) activation and proteasome activity are essential for this novel post-translational regulation of PKR.
Area of Science:
- Molecular Biology
- Immunology
- Virology
Background:
- Double-stranded RNA-dependent protein kinase (PKR) mediates interferon (IFN) antiviral actions and is crucial for signal transduction and immunomodulation.
- Understanding PKR regulation is vital for developing therapeutics for viral infections, cancer, and immune disorders.
Purpose of the Study:
- To investigate the regulatory mechanisms of PKR activity, specifically how phorbol 12-myristate 13-acetate (PMA) affects PKR levels and function.
- To elucidate the role of protein kinase C (PKC) and proteasome pathways in PMA-induced modulation of PKR.
Main Methods:
- IFN-treated mouse fibroblast cells were treated with PMA and polyinosinic-polycytidylic acid (poly I:C).
- PKR autophosphorylation levels were assessed.
- Western blot analysis was used to detect PKR protein levels.
- PKC and proteasome inhibitors were employed to investigate signaling pathways.
Main Results:
- PMA decreased PKR autophosphorylation in a dose- and time-dependent manner.
- Poly I:C enhanced IFN-induced PKR activity but did not reverse the PMA effect.
- PMA-induced reduction in PKR autophosphorylation was due to PKR protein degradation.
- PKC activity and an active proteasome were required for PMA-induced PKR down-regulation.
Conclusions:
- PKC activation by PMA leads to PKR protein degradation via the proteasome.
- This study identifies a novel mechanism for post-translational regulation of PKR activity.
- Findings provide insights into PKR regulation relevant to therapeutic development.